tbuckley/cabot-search huggingface dataset:
LAW AND MEDICINE
Authors: Veronica M. O'Hern
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Radiation Hysteria
Authors: C. C. McClure
Journal: JAMA (1961)

<h3>To the Editor:—</h3> The present cycle of "radiation hysteria" is doing more damage than any of the others. The laity are asking "Will this x-ray of my chest do me or my offspring any harm?" Articles appearing in nonprofessional periodicals have the public and some professional men wondering if the routine x-ray examination is safe. After 42 years' experience, I feel that I can answer that question up to the present. What might happen a hundred years from now, no one knows. The human race has received small amounts of x-ray since time began. Beginning 42 years ago, I was called on many times to x-ray possible cases of pregnancy in young suspects. Many positive diagnoses were made and I am now x-raying the grandchildren of those babies and have yet to see my first case of genetic mutation in a single one. All radiologists have seen their share of
In vitro Toxicity and Transformation Potency of Nickel Compounds
Authors: K. Hansen, R. M. Stern
Journal: Environmental Health Perspectives (1983)

An in vitro bioassay utilizing BHK-21 cells in culture is used to determine the relative transformation potential of a number of nickel compounds including, as relatively insoluble particulates a known carcinogen (Ni3S2) and several oxides either of commercial interest or found in the working environment in the metal industry (e.g., NiO), and a soluble salt [Ni(CH3COO)2]. Although a wide range of transformation potency is found as a function of the dose of Ni per area of culture, all substances produce the same number of transformed colonies at the same degree of toxicity (e.g., 50% survival). If toxicity is a direct measure of intracellular concentration, then apparently nickel per se is the ultimate transforming agent independent of source or uptake mechanism.
The Biochemistry of Medicine.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Information in Tables and Figure Caption
Journal: JAMA Neurology (2014)

Margaux F. Keller, BA; Luigi Ferrucci, MD, PhD; Andrew B. Singleton, PhD; Pentti J. Tienari, MD; Hannu Laaksovirta, MD; Gabriella Restagno, MD; Adriano Chiò, MD; Bryan J. Traynor, MD, PhD; Michael A. Nalls, PhD
Advances in diabetic retinopathy could save sight, money with more frequent eye exams
Authors: P. Cotton
Journal: JAMA (1990)

EYE EXAMINATIONS every 6 months, it is argued, could save millions of dollars by detecting diabetic retinopathy before damage becomes irreversible. "If the federal government provided funds to screen and treat patients who have diabetic eye disease, the actual cost to taxpayers in the long run would be far less" than paying for the disability of blindness, says Jonathan C. Javitt, MD, MPH, assistant professor of ophthalmology, Georgetown University School of Medicine, and associate director, Worthen Center for Eye Care Research, Washington, DC. He presented the analysis at a Research to Prevent Blindness seminar in Universal City, Calif. The Georgetown study is expected to boost American Academy of Ophthalmology and National Eye Institute efforts to persuade physicians and patients to act on proven advances in preventing this leading cause of blindness among working-age Americans. Another, very preliminary, study presented at the seminar suggests that antihistamines may prevent the process that
α4-integrin-VCAM-1 binding mediates G protein–independent capture of encephalitogenic T cell blasts to CNS white matter microvessels
Authors: Peter Vajkoczy, Melanie Laschinger, Britta Engelhardt
Journal: Journal of Clinical Investigation (2001)

Direct in vivo evidence is still lacking for α4-integrin–mediated T cell interaction with VCAM-1 on blood-brain barrier–endothelium in experimental autoimmune encephalomyelitis (EAE). To investigate a possible α4-integrin–mediated interaction of encephalitogenic T cell blasts with VCAM-1 on the blood-brain barrier white matter endothelium in vivo, we have developed a novel spinal cord window preparation that enabled us to directly visualize CNS white matter microcirculation by intravital fluorescence videomicroscopy. Our study provides the first in vivo evidence that encephalitogenic T cell blasts interact with the spinal cord white matter microvasculature without rolling and that α4-integrin mediates the G protein–independent capture and subsequently the G protein–dependent adhesion strengthening of T cell blasts to microvascular VCAM-1.
Shall The Journal be Removed to Washington?
Authors: Arthur Young
Journal: JAMA (1891)

<h3>To the Editor:</h3> —LetThe Journalremain in Chicago. It is certain that the place wherein it is published will largely impress its own character upon it. The fact that Chicago is not only<i>the</i>geographic and railroad centre of our country, but is also a great metropolis, with immense and constantly increasing medical, literary and business interests springing up within it and flowing toward it from all parts of the Union, will give toThe Journalan<i>éclat</i>and high professional position, that will add greatly to its power, and widen its influence beyond anything that could possibly be hoped for were it a fixture in Washington. It is appropriate that the representative of American medicine should have its home in the representative American city, which is Chicago. This city can also place at the disposal of the management a wealth of resource second to but one in this
STILL "SCRAPPING."
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SHOULD THE TUBERCULOUS PATIENT KNOW THE TRUTH REGARDING HIS CONDITION?*
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
AIDS giving rise to cardiac problems
Authors: P. Cotton
Journal: JAMA (1990)

A HIDDEN WAVE of heart disease could surface as the human immunodeficiency virus (HIV) epidemic continues to evolve. An accurate assessment of incidence has not been made, says the Centers for Disease Control, Atlanta, Ga. But more than 150 reports on acquired immunodeficiency syndrome (AIDS)-related heart complications are in the scientific literature. Pathologists are finding inflammation, myopathy, and neoplasms in as many as two thirds of autopsies on patients with AIDS. The rates are lowest among white homosexual men and highest in the nonwhite and intravenous drug—using populations through which the epidemic is now spreading. "We feel that cardiac problems might emerge" (become symptomatic) during the increased survival time resulting from advances in treating the opportunistic infections that cause most AIDS-related deaths, says Constance Weinstein, PhD, chief of the cardiac diseases branch of the National Heart, Lung, and Blood Institute, Bethesda, Md (NHLBI). A review in the April 1989 issue
Black Psychiatrists
Journal: JAMA (1999)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Letter: Uticillin.
Authors: E T Knudsen
Journal: BMJ (1974)

while at the same time favouring the use of another anaesthetic agent or technique which may have even greater dangers.The fact that the Medical Research Council (27 July, p. 268) is prepared to support prospective studies on this aspect serves to emphasize that, whatever some doctors may care to believe, no cause-and-effect relationship has yet been established between halothane and hepatic damage.Finally, since Dr.
Hypnosis
Authors: K. Davison
Journal: BMJ (1963)

<h3>Background:</h3> International studies have observed inequities in stage at diagnosis of melanoma. As this has not been sufficiently studied in Canada, the purpose of this study was to investigate whether there are disparities in the diagnosis of advanced-thickness melanoma in the province of Ontario. <h3>Methods:</h3> In this retrospective population-based cohort study, we obtained, abstracted and linked pathology reports for a 65% random sample of all cases of invasive cutaneous melanoma in Ontario from 2007 to 2012 in the Ontario Cancer Registry. Cases without pathology reports or with unreported thickness were excluded from the primary analysis. Associations between advanced melanoma (thickness &gt; 2.0 mm) and patient, health-system and tumour factors were described and analyzed using multivariable modified Poisson regression. <h3>Results:</h3> In total, 8042 patients had histologically confirmed melanoma and thickness information. Of these, 46.7% (<i>n</i> = 3755) were female, the median age at diagnosis was 62 years and 25.7% (<i>n</i> = 2069) had advanced melanoma. In multivariate analyses, advanced age (relative risk [RR] 1.53; 95% confidence interval [CI] 1.37–1.72), male sex (RR 1.12, 95% CI 1.05–1.20), lowest socioeconomic status quintile (RR 1.24; 95% CI 1.12–1.38) and health region (RR range 0.92–1.34, <i>p</i> = 0.005 for variable) were significantly associated with advanced melanoma. Presence of ulceration significantly modified many of these associations. <h3>Interpretation:</h3> Disparate rates of advanced melanoma according to patient and health system factors suggest there may be inequitable access to timely diagnosis of melanoma in Ontario. This highlights a potential opportunity for system improvement to ensure timely and equitable access to melanoma care.
Alopecia areata.
Journal: BMJ (1977)

Alopecia areataThe diagnosis of alopecia areata is usually straightforward, but its course is often unpredictable and the condition is certainly frustrating to treat.In the nineteenth century it was commonly confused with ringworm, partly because of incon- sistencies in nomenclature and also because of inadequate mycological techniques.By 1900 most authorities had accepted that this form of alopecia was not an infection but otherwise found few areas of agreement about its cause.The
SOCIETY NEWS.
Journal: JAMA (1894)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Premature Synostosis of the Sagittal Suture and Its Treatment: A Modification of the Linear Craniectomy and the Use of Synthetic Fabrics
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Obituaries
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Otolaryngology--head and neck surgery
Authors: B. J. Bailey
Journal: JAMA (1989)

Foremost among the events of 1988 in our specialty is the creation of a new institute within the National Institutes of Health to serve the needs of those who practice our discipline and the needs of our patients. The new Institute on Deafness and Other Communication Disorders is certain to stimulate many new avenues of basic and clinical investigation and to accelerate the introduction of improved patient care methods and technology into our practices. The implantable electronic cochlear prosthesis is a major new technology that benefits deaf patients. During the past year, the clinical trials of cochlear implantation in children have been completed, and the Food and Drug Administration's Advisory Panel on Ear, Nose and Throat Devices has recommended the approval of the surgically implanted cochlear prosthesis for children. The preponderance of evidence supports its safety and efficacy in children, and it is anticipated that it will greatly benefit social
Abdominal Surgery
Authors: Claude E. Welch
Journal: New England Journal of Medicine (1960)

THE last paper on this subject appeared in the Journal just over two years ago.1 Since that time several comprehensive progress reports on specific subjects that must be covered much more briefly in this review have appeared. They include discussions of duodenal ulcer by Brooks and Moore,2 on the pancreas by Warren and Cattell,3 on proctology by Hayden,4 on Hirschsprung's disease by Swenson5 and on portal hypertension by Leevy, Cherrick and Davidson.6 The selection of the relatively small number of references for inclusion in this survey will, in controversial fields, reflect to some degree my personal opinions. Furthermore, some papers . . .
Colour Plates
Journal: Neuro-Oncology (2012)

The colour illustrations for Chapters 4, 5, 6, 8 and 14 are included, as follows: Plates 4.1, 4.2, 4.3, 4.4, 4.5 Plate 5.6 Plate 6.7 Plate 8.8 Plates 14.9, 14.10, 14.11
Shoulder enlargement as the presenting sign in syringomyelia. Report of two cases and review of the literature
Authors: J. C. Sackellares
Journal: JAMA (1976)

Two adult patients had painful enlargement of the shoulder and complete destruction of the humeral head. Angiograms of the shoulder showed highly vascular lesions in both patients. Both patients had syringomyelia, for which the swollen shoulder was the first manifestation. (<i>JAMA</i>236:2878-2879, 1976)
Contingency Management for the Treatment of Methamphetamine Use Disorders
Authors: John Roll
Journal: American Journal of Psychiatry (2006)

Objective: Theory and some preliminary evidence suggest that contingency management may be an effective treatment strategy or adjunct to psychosocial treatment for methamphetamine use disorders. An experimentally rigorous investigation on the topic was provided by a large multisite trial conducted under the auspices of the Clinical Trials Network of the National Institute on Drug Abuse. Method: The authors report data on 113 participants who were diagnosed with methamphetamine abuse or dependence. They were randomly assigned to receive 12 weeks of either treatment as usual or treatment as usual plus contingency management. Urine samples were tested for illicit drugs, and breath samples were tested for alcohol. The reinforcers for drug-negative samples were plastic chips, some of which could be exchanged for prizes. The number of plastic chips drawn increased with each week of negative samples but was reset to one after a missed or positive sample. Results: The participants in both groups remained in treatment for equivalent times, but those receiving contingency management in addition to usual treatment submitted significantly more negative samples, and they were abstinent for a longer period of time (5 versus 3 weeks). Conclusions: These results suggest that contingency management has promise as a component in treatment strategies for methamphetamine use disorder.